INTRODUCTION
Vertical transmission of group B streptococcus (GBS) from a vagina colonized mother to her infant during labor can cause life-threatening infections in newborn. Maternal GBS colonization is associated with increased risk of transfer to the neonatal intensive care unit in term infants (Brigtsen et al., 2015) . Neonatal sepsis and pneumonia are the most important GBS-related neonatal infections, followed by meningitis, celullitis, osteomyelitis and septic arthritis (Schrag et al., 2002) . GBS is also associated with invasive and noninvasive infections in pregnant women and non-pregnant adults, especially the elderly or those with underlying medical conditions (Dutra et al., 2014). The centers of disease control and prevention (CDC) recommended antenatal screening for all pregnant women at 35-37 weeks of gestation for the prevention of early onset GBS disease with vaginal/rectal cultures and selective IAP administration to GBS-positive women (CDC, 2010). Prenatal screening by culture is currently the gold standard method for detection of anogenital GBS colonization. However, cultures require several days (24-72 h) to yield results, thus precluding their use for intrapartum screening and these are only performed at 35-37 weeks gestation (Emonet et al., 2013). For this reason, there is a requirement for a rapid diagnostic test to detect GBS colonization status of women in labour, those in preterm labour or women who have not had prenatal care (Gavino and Wang, 2007 ). An ideal screening test for GBS colonization is which could accurately identify pregnant women who carry the bacteria (even low-count bacteria carriers) and presenting a short turnaround time (de-Paris et al., 2011). New rapid molecularbased tests, such as polymerase chain reaction (PCR), can detect GBS within hours. They have the potential to be used intrapartum and to allow for selective IAP in women carrying GBS (Emonet et al., 2013). PCR assays have been developed to detect a variety of genetic targets, including genes encoding C protein, the 16S rRNA, and the 16S-23S spacer region (Bergeron and Ke, 2004) . The objective of our study was to evaluate PCR targeting cfb and scpB genes as a screening method for detection of maternal colonization of GBS compared to culture.
MATERIAL AND METHODS

Detection of GBS by culture
The study included 120 consenting pregnant women, between 35 and 37 weeks of gestation, attending the antenatal clinic of Suez Canal University Hospital in Ismailia, Egypt. Vaginal/rectal swabs were collected from each patient and inoculated into Lim broth; a selective medium consisting of Todd-Hewitt broth supplemented with 10 g/ml colistin and 15 g/ml nalidixic acid. Cultures are incubated at 37°C for 24 hours and then subcultured onto CNA medium (Colombia blood agar supplemented with 10 μg/ml colistin and 15 μg/ml nalidixic acid) and incubated at 37°C for 24 hours. Colonies with a narrow zone of beta hemolysis were suggestive of GBS and were further identified by being gram positive cocci, catalase negative, CAMP (Christie, Atkins, and MunchPeterson)positive and hippurate hydrolysis positive. Confirmation was done by a streptococcus latex agglutination test (BIOTEC Laboratories).
Detection of GBS by PCR targeting cfb and scpB genes
All the 120 specimens were tested by PCR for detection of GBS using two sets of primers; one targeting the cfb gene which encodes the CAMP factor and the other one targeting the scpB gene which encodes C5a peptidase. After DNA extraction, PCR reaction for each assay was performed in a 25 μl volume containing 2.4 μl DNA template, 12.5 μl of 2X power Taq PCR master mix (QIAGEN, Germany), 0.7 μM of each primer. The volume for each PCR reaction was completed to 25 μl with nuclease free water. Table (1) . A negative control consisting of the reaction mixture and nuclease-free water was added in each run. In addition, a reference S. agalactiae (ATCC 12386) strain was used as positive control.
Group B Streptococcus (GBS) is a leading cause of neonatal morbidity and mortality. Molecular based tests, such as polymerase chain reaction (PCR), can detect GBS within hours and can be used intrapartum allowing for selective intrapartum antibiotic prophylaxis (IAP) in women carrying GBS. The aim of this work was to evaluate PCR as a rapid screening method for detection of maternal colonization of GBS compared to culture. Vaginal/rectal swabs were collected from 120 pregnant women at 35-37 weeks of gestation and cultured on CNA medium. GBS was identified by gram staining and catalase, hippurate and CAMP tests and confirmed by latex agglutination for GBS antigens. PCR was done using two assays; one targeting the cfb gene and the other targeting the scpB gene. Results revealed thatGBS colonization was detected in 15%, 23.3% and 21.7% of pregnant women by culture, cfb PCR assay and scpB PCR assay respectively. cfb PCR assay showed 100% sensitivity and 90.2% specificity whereas scpB PCR assay showed 94.4% sensitivity and 91.2% specificity. PCR could detect GBS genome at a concentration of as low as 10 -2 for cfb PCR and 10 -3 for scpB PCR. In conclusion, PCR is a rapid, specific and sensitive tool for detection of maternal colonization of GBS. PCR assay targeting scpB gene is more sensitive than that targeting cfb gene. Amplifications were carried out in a Thermocycler (Eppendorf, USA) and consisted of initial denaturation step at 94˚C for 3 minutes followed by 33 cycles of 45 seconds at 94˚C, 45 seconds at 57˚C, and one minute at 72˚C. These are followed by an extension step at 72˚C for 7 minutes. The amplicons obtained were run on 2% agarose gel with 0.5 µg/ml ethidium bromide in a Tris-borate-EDTA buffer. The gels were run in an electrophoresis gel tank at 100V for 30 minutes. After electrophoresis the sizes of DNA fragments were calculated using 100 bp ladder as DNA molecular size standards. Each gel run contained a negative control and a positive control. Finally, the DNA was visualized and photographed using a Gel Documentation System (BioSpectrum 310 Imaging System, USA).
Evaluation of PCR assay
The specificity and sensitivity of PCR assay using the previously mentioned primers were evaluated compared to culture. The analytical sensitivity (i.e. the detection limit or the minimal number of genome copies that canbe detected) of each assay was determined by testing serial 10-fold dilutions of purified genomic DNA from a reference GBS strain (ATCC 12386), containing from 10 -1 to 10 -7 CFU/ml and starting with a concentration of 38.1 ng/µl. The stock DNA concentration was measured using the nanodrop technique (NanoDrop ND-1000 spectrophotometer). Each 10-fold dilution was added directly to the PCR reaction mixture before PCR amplification for each of the cfb and scpB genes. Amplifications were carried out using the same conditions used in the two PCR assays carried out before. A negative control was included in the reaction for both genes. After gel electrophoresis, the DNA was visualized and photographed. The analytical sensitivity of each of the two PCR assays was determined as the least concentration of genomic DNA at which the PCR gave a detectable band.
RESULTS AND DISCUSSION
Eighteen samples out of 120 were identified as GBS by culture. The rate of maternal colonization of GBS by the culture method was 15%. Twenty eight specimens (23.3%) were positive for GBS using the cfb PCR assay. Positive specimens showed specific bands of approximately 153bp in size (Figure 1 ). Twenty six specimens (21.7%) were positive for GBS using the scpB PCR assay. Positive specimens showed specific bands of approximately 255bp in size ( Figure  2 ). All the eighteen culture positive specimens were also positive by the cfb PCR assay while only 17 of them were positive by scpB PCR assay. Among the 102 culture negative specimens, 10 were positive by cfb PCR assay while 9 were positive by scpB PCR assay. In comparison to the culture method, the cfb PCR assay exhibited 100% sensitivity and 90.2% specificity with a positive predictive value of 64.3% and a negative predictive value of 100% whereas the scpB PCR assay revealed 94.4% sensitivity and 91.2% specificity with a positive predictive value of 65.4% and a negative predictive value of 98.9%. On determining the detection limit of PCR, it was found that both cfb and scpB PCR assays were able to detect GBS DNA at a concentration of 0.01(10 -2 ), but the cfb PCR assay was slightly more sensitive being able to detect GBS DNA at a lower concentration (one log 10 difference;10 -3 ) (Figure 3 ). Although culture methods are the current standard for prenatal GBS screening, the implementation of more sensitive molecular diagnostic tests may be able to further reduce the risk of early-onset GBS infection (Buchan et al., 2015) . Using the culture method, this study reported that the rate of GBS colonization in pregnant women was 15%. This rate varies greatly among countries. (Ghaddar et al., 2014) .These variations in colonization rates relate to intrinsic differences in populations and to lack of standardization in culture methods employed for ascertainment, Also, a change in the prevalence over time, or real population differences account for some of the disparity in these reported prevalence rates. In spite of the great variation of prevalence rates, Le and Heath (2013) reported that the serotype distribution of GBS isolates is similar in Africa, Western Pacific, Europe, the Americas and the Eastern Mediterranean regions and has not changed over the past 30 years. This study showed that PCR using cfb and scpB genes was more sensitive for detection of GSB than the culture method as the rate of detection was 15% by the culture method compared to 23. Regarding the analytical sensitivity assessment of PCR assays, it was evident that the cfb PCR assay was slightly more sensitive being able to detect GBS DNA at a lower concentration (10 -3 ) than that detected by the scpB PCR assay (10 -2 ). The PCR assays in this study required about 100 minutes for sample processing, PCR amplification, and gel electrophoresis and even with using a previous incubation in selective broth, it required 24 hours to give the final result. This offers an advantage over the culture method which is a time-consuming method requiring at least 48 hours for full GBS identification.
CONCLUSION
Although more expensive than the standard culture method, the PCR technique targeting cfb and scpB genes is rapid, specific and has a higher sensitivity in detecting GBS carriers during pregnancy with the scpB PCR assay being more sensitive than the sfb PCR assay. PCR allows for accurate diagnosis of GBS which will be translated into more rational use of antibiotics and more effective treatment of carrier females leading to reduction of newborn morbidity and mortality. Yet, the cost-effectiveness of such PCR tests need to be more elucidated by further studies to see if it can be used as a routine screening method in centers with maternity wards.
